1. TEAM 4 Hussein El shamy, Engyhelaly, Ayaat Ali, EslamEl shahat and MarwanFelafel

2. Where are we now? Novartis is a great company which works hard to help patients. The major targets of Novartis are patients’ health and patients’ trust. Novartis want to cover all patients who have chronic myeloid leukemia ( CML ) in Egypt. Novartis produces 2nd line treatment for ( CML ) which is called Pluto.

3. Executive summary Our aim is to be ranked the second in the market within 5 years. The project is prepared to invest 660,000L.E. and to gain 4,320,000l in the first year with an annual increase in the profit around 10%.

5. Effective & safe.

6. Former experience.

10. Where do we want to be? Mission statement

12. Strategy Objectives Objectives Mission Goals

14. Recognition as a leader in the leukemia market

15. Higher levels of customer satisfaction and compliance

17. Augmenting the market share by: 19% Increasing the number of targeted patients by 304 patients. Increasing sales by 5,472,000 LE Improving the drug ranking against competitors 2nd Developing a good ROI & KPI

19. Pluto is an innovative product

20. Faster 6-9 months only

22. Then we will decrease the price by 15%.

23. Medical rep. (4 and 1 DM)

24. Sessions in conferences

26. How might we get there?

27. Another problem is: Dasatinib But our drug is: MoreSelective With LessAdverse effects AND it is Cheaper!

28. Strategy implementation and evaluation (financial plan)

29. Strategy implementation and evaluation (financial plan)

31. Action Plan

32. How can we ensure our arrival? Key Performance Indicators:

33. Thank You